Uterine papillary serous carcinoma: Comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy

Gynecologic Oncology

Volumn 91, Issue 3, 2003, Pages 470-475

  Huh, Warner K ^a,e   Powell, Matthew ^b   Leath III, Charles A ^a   Straughn Jr , J Michael ^a   Cohn, David E ^c   Gold, Michael A ^d   Falkner, Camille A ^d   Carey, Delicia E ^a   Herzog, Thomas ^b   Fowler, Jeffrey M ^c   Partridge, Edward E ^a   Kilgore, Larry C ^a   Alvarez, Ronald D ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PACLITAXEL;

ASCITES FLUID CYTOLOGY; CANCER STAGING; CLINICAL TRIAL; FISHER EXACT TEST; HUMAN; HYSTERECTOMY; PAPILLARY CARCINOMA; PARAAORTIC LYMPH NODE; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SALPINGOOOPHORECTOMY; STATISTICAL ANALYSIS; TREATMENT OUTCOME; UTERINE PAPILLARY SEROUS CARCINOMA; UTERUS CARCINOMA;

EID: 12144291323     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2003.08.027     Document Type: Article

References (33)

1. Lauchlan S.C. Tubal (serous) carcinoma of the endometrium. Arch Pathol Lab Med. 105:1981;615-618.
2. Hendrickson M., Ross J., Eifel P.J., Cox R.S., Martinez A., Kempson R. Adenocarcinoma of the endometrium analysis of 256 cases with carcinoma limited to the uterine corpus. Pathology review and analysis of prognostic variables. Gynecol Oncol. 13:1982;373-392.
3. Hendrickson M.R., Ross J., Eifel P.J., Martinez A., Kempson R. Uterine papillary serous carcinoma a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol. 6:1982;93-108.
4. O'Hanlan K.A., Levine P.A., Harbatkin D., Feiner C., Goldberg G.L., Jones J.G., Rodriguez-Rodriguez L. Virulence of papillary endometrial carcinoma. Gynecol Oncol. 37:1990;112-119.
5. Goff B.A., Kato D., Schmidt R.A., Ek M., Ferry J.A., Muntz H.G., Cain J.M., Tamimi H.K., Figge D.C., Greer B.E. Uterine papillary serous carcinoma patterns of metastatic spread. Gynecol Oncol. 54:1994;264-268.
6. Geisler J.P., Geisler H.E., Melton M.E., Wiemann M.C. What staging surgery should be performed on patients with uterine papillary serous carcinoma. Gynecol Oncol. 74:1999;465-467.
7. Sherman M.E., Bitterman P., Rosenshein N.B., Delgado G., Kurman R.J. Uterine serous carcinoma, a morphologically diverse neoplasm with unifying clinicopathological factors. Am J Surg Pathol. 16:1992;600-610.
8. Abeler V.M., Kjorstad K.E. Serous papillary serous carcinoma of the endometrium a histopathologic study of 22 cases. Gynecol Oncol. 39:1990;266-271.
9. Ward B.G., Wright R.G., Free K. Papillary carcinomas of the endometrium. Gynecol Oncol. 39:1990;347-351.
10. Jeffrey J.F., Krepart G.V., Loctoki R.J. Papillary serous adenocarcinoma of the endometrium. Obstet Gynecol. 67:1986;670-674.
11. Matthews R.P., Hutchinson-Colas J., Maiman M., Fruchter R.G., Gates J., Gibbon D., Remy J.C., Sedlis A. Papillary serous and clear cell type lead to poor prognosis of endometrial carcinoma in black women. Gynecol Oncol. 65:1997;206-212.
12. Sutton G.P., Brill L., Michael H., Stehman F.B., Ehrlich C.E. Malignant papillary lesions of the endometrium. Gynecol Oncol. 27:1987;294-304.
13. Chambers J.T., Merino M., Kohorn E.I., Peschel R.E., Schwartz P.E. Uterine papillary serous carcinoma. Obstet Gynecol. 69:1987;109-113.
14. Carcangiu M.L., Chambers J.T. Uterine papillary serous carcinoma a study on 108 cases with emphasis on the prognostic significance of associated endometroid carcinoma, absence of invasion, and concomitant ovarian carcinoma. Gynecol Oncol. 47:1992;298-305.
15. Lee K.R., Belinson J.L. Papillary serous adenocarcinoma of the endometrium a clinicopathologic study of 19 cases. Gynecol Oncol. 46:1992;51-54.
16. Dunton C.J., Balsara G., McFarland M., Hernandez E. Uterine papillary serous carcinoma a review. Obstet Gynecol Surv. 46:1991;97-102.
17. Christopherson W.M., Alberhasky R.C., Connelly P.J. Carcinoma of the endometrium II papillary adenocarcinoma a clinical pathological study of 46 cases. Am J Clin Pathol. 77:1982;534-540.
18. Gallion H.H., van Nagell J.R. Jr, Powell D.F., Donaldson E.S., Higgins R.V., Kryscio R.J., Pavlik E.J., Nelson K. Stage I serous papillary carcinoma of the endometrium. Cancer. 63:1989;2224-2228.
19. Ramirez-Gonzales C.E., Adamsons K., Mangual-Vasquez T.Y., Wallach R.C. Papillary adenocarcinoma in the endometrium. Obstet Gynecol. 70:1987;212-215.
20. Nicklin J.L., Copeland L.J. Endometrial papillary serous carcinoma patterns of spread and treatment. Clin Obstet Gynecol. 39:1996;686-695.
21. Creasman W., Morrow C., Bundy B., Homesley H., Graham J., Heller P. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group study. Cancer. 60:1987;2035-2041.
22. Cirisano F.D., Robboy S.J., Dodge R.K., Bentley R.C., Krigman H.R., Synan I.S., Soper J.T., Clarke-Pearson D.L. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrioid cancers when compared with endometrioid carcinoma. Gynecol Oncol. 77:2000;55-65.
23. Bristow R.E., Asrari F., Trimble E.L., Montz F.J. Extended surgical staging for uterine papillary serous carcinoma survival outcome of locoregional (Stage I-III) disease. Gynecol Oncol. 81:2001;279-286.
24. Kato D.T., Ferry J.A., Goodman A., Sullinger J., Scully R.E., Goff B.A., Fuller A.F., Rice L.W. Uterine papillary serous carcinoma (UPSC) a clinicopathologic study of 30 cases. Gynecol Oncol. 59:1995;384-389.
25. Grice J., Ek M., Greer B., Koh W.J., Muntz H.G., Cain J., Tamimi H., Stelzer K., Figge D., Goff B.A. Uterine papillary serous carcinoma evaluation of long-term survival in surgically staged patients. Gynecol Oncol. 69:1998;69-73.
26. Gitsch G., Friedlander M.L., Wain G., Hacker N.F. Uterine papillary serous carcinoma. A clinical study. Cancer. 75:1995;2239-2243.
27. Tay E.H., Ward B.G. The treatment of uterine papillary serous carcinoma (UPSC) are we doing the right thing? Int J Gynecol Cancer. 9:1999;463-469.
28. Bancher-Todesca D., Neunteufel W., Williams K.E., Prainsack D., Breitenecker G., Friedlander M.L., Hacker N.F. Influence of postoperative treatment on survival in patients with uterine papillary serous carcinoma. Gynecol Oncol. 71:1998;344-347.
29. Craighead P.S., Sait K., Stuart G.C., Arthur K., Nation J., Duggan M., Guo D. Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994. Gynecol Oncol. 77:2000;248-253.
30. Gitsch G., Friedlander M.L., Wain G., Hacker N.F. Uterine papillary serous carcinoma a clinical study. Cancer. 75:1995;2239-2243.
31. Tay E.H., Ward B.G. The treatment of uterine papillary serous carcinoma (UPSC) are we doing the right thing? Int J Gynecol Cancer. 9:1999;463-469.
32. Bancher-Todesca D., Neunteufel W., Williams K.E., Prainsack D., Breitenecker G., Friedlander M.L., Hacker N.F. Influence of postoperative treatment on survival in patients with uterine papillary serous carcinoma. Gynecol Oncol. 71:1998;344-347.
33. Craighead P.S., Sait K., Stuart G.C., Arthur K., Nation J., Duggan M., Guo D. Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994. Gynecol Oncol. 77:2000;248-253.